Voices
Fidel Rubagumya: Survival Outcomes of Cervical Cancer Patients Treated With EBRT Boost in Rwanda
Fidel Rubagumya

Fidel Rubagumya: Survival Outcomes of Cervical Cancer Patients Treated With EBRT Boost in Rwanda

Fidel Rubagumya, Adjunct Associate Professor at the Geisel School of Medicine, shared a post on X:

“Published: In this cohort of 577 women with cervical cancer treated in Rwanda, we show that in settings without brachytherapy, external beam radiotherapy boost with concurrent chemotherapy can achieve meaningful survival. The 2-year OS was 62.2% with CRT and 76.4% with induction chemotherapy + CRT.”

Title: Survival outcomes of cervical cancer patients treated with external beam radiotherapy boost in Rwanda

Authors: Fidel Rubagumya, Viswanathan Shankar, Vincent Kwizera, Diane A. Ndoli, Claire Umubyeyi, Achille Manirakiza, Alain Fabrice Mizero, Emmanuel Mutabazi, Felix Ngaji, Theoneste Maniragaba, Kenneth K. Rutikanga, Jackson Muvunyi, Pacifique Mugenzi, Jean D’amour Kamanzi, Laurent Rangira, Emmanuel Nkurunziza, Cyprien Barihamwe, Bassem Zaki, Mary Chamberlin, Leon Mutesa, Rafi Kabir

Read the Article

Fidel Rubagumya

Other articles featuring Dr. Rubagumya on OncoDaily.

Achille Manirakiza Alain Fabrice Mizero Bassem Zaki cancer Claire Umubyeyi Cyprien Barihamwe Diane A. Ndoli Emmanuel Mutabazi Emmanuel Nkurunziza Felix Ngaji Fidel Rubagumya Jackson Muvunyi Jean D’amour Kamanzi Kenneth K. Rutikanga Laurent Rangira Leon Mutesa Mary Chamberlin OncoDaily Oncology Pacifique Mugenzi Rafi Kabir Rwanda Theoneste Maniragaba Vincent Kwizera Viswanathan Shankar